Business Description
Kabra Drugs Ltd
ISIN : INE323K01017
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1.4 | |||||
Debt-to-Equity | -1.62 | |||||
Debt-to-EBITDA | -3.15 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -131.6 | |||||
3-Year EPS without NRI Growth Rate | -78.2 | |||||
3-Year FCF Growth Rate | -97.3 | |||||
3-Year Book Growth Rate | -197.9 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.98 | |||||
6-1 Month Momentum % | 40.43 | |||||
12-1 Month Momentum % | 29.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.4 | |||||
Quick Ratio | 0.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -12.27 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -71.9 | |||||
ROIC % | -34.33 | |||||
ROC (Joel Greenblatt) % | -89.3 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -9.66 | |||||
EV-to-EBITDA | -9.66 | |||||
EV-to-FCF | -13.84 | |||||
Earnings Yield (Greenblatt) % | -10.35 | |||||
FCF Yield % | -10.71 | |||||
Forward Rate of Return (Yacktman) % | -0.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kabra Drugs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | |||
EPS (TTM) (₹) | -1.16 | ||
Beta | -0.32 | ||
Volatility % | 56.31 | ||
14-Day RSI | 99.98 | ||
14-Day ATR (₹) | 0.015783 | ||
20-Day SMA (₹) | 7.33 | ||
12-1 Month Momentum % | 29.08 | ||
52-Week Range (₹) | 3.18 - 7.54 | ||
Shares Outstanding (Mil) | 4.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kabra Drugs Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kabra Drugs Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Kabra Drugs Ltd Frequently Asked Questions
What is Kabra Drugs Ltd(BOM:524322)'s stock price today?
When is next earnings date of Kabra Drugs Ltd(BOM:524322)?
Does Kabra Drugs Ltd(BOM:524322) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |